Observational studyVirology journal2025
A novel nomogram for the early identification of coinfections in elderly patients with coronavirus disease 2019.
Observational study in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesThis study aimed to establish a novel and practical nomogram for use upon hospital admission to identify coinfections among elderly patients with coronavirus disease 2019 (COVID-19) to provide timely intervention, limit antimicrobial agent overuse, and finally reduce unfavourable outcomes.
methodsThis prospective cohort study included COVID-19 patients consecutively admitted at multicenter medical facilities in a two-stage process. The nomogram was built on the multivariable logistic regression analysis. The performance of the nomogram was assessed for discrimination and calibration using receiver operating characteristic curves, calibration plots, and decision curve analysis (DCA) in rigorous internal and external validation settings. Two different cutoff values were determined to stratify coinfection risk in elderly patients with COVID-19.
resultsThe coinfection rates in elderly patients determined to be and 26.61%. The nomogram was developed with the parameters of diabetes comorbidity, previous invasive procedure, and procalcitonin (PCT) level, which together showed areas under the curve of 0.86, 0.82, and 0.83 in the training, internal validation, and external validation cohorts, respectively. The nomogram outperformed both PCT or C-reactive protein level alone in detecting coinfections in elderly patients with COVID-19; in addition, we found the nomogram was specific for the elderly compared to non-elderly group. To facilitate clinical decision-making among elderly patients with COVID-19, we defined two cutoff values of prediction probability: a low cutoff of 6.65% to rule out coinfections and a high cutoff of 27.79% to confidently confirm coinfections.
conclusionsThis novel nomogram will assist in the early identification of coinfections in elderly patients with COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.